Successful treatment of high-risk gestational trophoblastic disease in a patient with intolerance to standard chemotherapy (clinical case)

Cover Page

Cite item

Full Text

Abstract

Gestational trophoblastic disease is a rare tumor highly sensitive to systemic drug therapy. The standard regimens of chemotherapy of I and II lines for patients in the high-risk group for gestational trophoblastic disease are the EMA-CO, EMA-EP and TP/TE regimens, which have been demonstrated to be effective and require adherence to drug doses and intervals of administration. If these criteria are not met, the risk of developing resistance with an unfavorable outcome for patients is extremely high. The situation is extremely difficult when a patient has an absolute allergic intolerance to one of the components of standard regimens, which is presented in a clinical case.

About the authors

G. M. Teletaeva

N.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia

Author for correspondence.
Email: drteletaeva@yahoo.com
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758 Russian Federation

E. A. Ulrikh

N.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia; V.A. Almazov National Medical Research Center, Ministry of Health of Russia

68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758
41 Kirochnaya St., Saint Petersburg 191015
2 Akkuratova St., Saint Petersburg 197341 Russian Federation

D. Kh. Latipova

N.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia

68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758 Russian Federation

A. I. Semenova

N.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia

68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758 Russian Federation

E. V. Levchenko

N.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia

68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758
41 Kirochnaya St., Saint Petersburg 191015 Russian Federation

D. G. Ulrikh

Saint Petersburg State Pediatric Medical University

2 Litovskaya St., Saint Petersburg 194100 Russian Federation

I. V. Berlev

N.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia

ORCID iD: 0000-0001-6937-2740
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758
41 Kirochnaya St., Saint Petersburg 191015 Russian Federation

T. Yu. Semiglazova

N.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia

68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758
41 Kirochnaya St., Saint Petersburg 191015 Russian Federation

S. A. Protsenko

N.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia

68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758 Russian Federation

A. F. Urmancheeva

N.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia

68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758
41 Kirochnaya St., Saint Petersburg 191015 Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36991 от  21.07.2009.